These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37982959)

  • 41. Current treatment patterns and medical costs for multiple myeloma in Japan: a cross-sectional analysis of a health insurance claims database.
    Uno S; Goto R; Suzuki K; Iwasaki K; Takeshima T; Ohtsu T
    J Med Econ; 2020 Feb; 23(2):166-173. PubMed ID: 31682533
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unnecessary axillary surgery for patients with node-negative breast cancer undergoing total mastectomy.
    Olaya W; Morgan JW; Lum SS
    Arch Surg; 2011 Sep; 146(9):1029-33. PubMed ID: 21930999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of coronavirus disease 2019 pandemic on breast cancer surgery using the National Database of Japan.
    Fujita M; Hashimoto H; Nagashima K; Suzuki K; Kasai T; Yamaguchi K; Onouchi Y; Sato D; Fujisawa T; Hata A
    Sci Rep; 2023 Mar; 13(1):4977. PubMed ID: 36973536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection.
    Kim GR; Choi JS; Han BK; Lee JE; Nam SJ; Ko EY; Ko ES; Lee SK
    Radiology; 2018 Jul; 288(1):55-63. PubMed ID: 29558291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.
    Prescott JD; Factor S; Pill M; Levi GW
    J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer.
    Liang SY; Phillips KA; Wang G; Keohane C; Armstrong J; Morris WM; Haas JS
    Med Care; 2011 Jun; 49(6):e1-8. PubMed ID: 21422962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021.
    Jaber Chehayeb R; Hood A; Wang X; Miksad R; Schellhorn Mougalian S; Lustberg MB; Wang SY; Greenup RA; Pusztai L; Kunst N
    JAMA Netw Open; 2022 Nov; 5(11):e2244204. PubMed ID: 36445704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost of treatment for breast cancer in central Vietnam.
    Hoang Lan N; Laohasiriwong W; Stewart JF; Tung ND; Coyte PC
    Glob Health Action; 2013 Feb; 6():18872. PubMed ID: 23394855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endoscopic sentinel lymph node biopsy and endoscopic axillary lymphadenectomy without liposuction in patients with early stage breast cancer.
    Fang J; Ma L; Zhang YH; Yang ZJ; Yu Y; Cao XC
    Surg Oncol; 2017 Dec; 26(4):338-344. PubMed ID: 29113649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disparities in the Use of Sentinel Lymph Node Dissection for Early Stage Breast Cancer.
    Nayyar A; Strassle PD; Schlottmann F; Jadi J; Moses CG; Black JA; Gallagher KK; McGuire KP
    J Surg Res; 2020 Oct; 254():31-40. PubMed ID: 32408028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
    Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
    BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Healthcare use and costs in early breast cancer: a patient-level data analysis according to stage and breast cancer subtype.
    Brandão M; Morais S; Lopes-Conceição L; Fontes F; Araújo N; Dias T; Pereira D; Borges M; Pereira S; Lunet N
    ESMO Open; 2020 Nov; 5(6):e000984. PubMed ID: 33234552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic accuracy of sentinel lymph node biopsy in determining the axillary lymph node metastasis.
    Okur O; Sagiroglu J; Kir G; Bulut N; Alimoglu O
    J Cancer Res Ther; 2020; 16(6):1265-1268. PubMed ID: 33342782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HER2-Positive Metastatic Breast Cancer: A Retrospective Cohort Study of Healthcare Costs in the Targeted-Therapy Age.
    Sussell JA; Sheinson D; Wu N; Shah-Manek B; Seetasith A
    Adv Ther; 2020 Apr; 37(4):1632-1645. PubMed ID: 32172510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy.
    Winchester DJ; Menck HR; Winchester DP
    Cancer; 1997 Jul; 80(1):162-7. PubMed ID: 9210722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of life after sentinel lymph node biopsy versus complete axillary lymph node dissection in early breast cancer: a 3-year follow-up study.
    Boguševičius A; Čepulienė D
    Medicina (Kaunas); 2013; 49(3):111-7. PubMed ID: 23893054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Relationship between health promotion volunteer experience and medical costs: Hoken-hodouin activities in Suzaka, Nagano].
    Imamura H; Murakami Y; Okamura T; Nishiwaki Y
    Nihon Koshu Eisei Zasshi; 2017; 64(1):25-35. PubMed ID: 28228631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The association between smoking cessation outpatient visits and total medical costs: a retrospective, observational analysis of Japanese employee-based public health insurance data.
    Suwa K; Yoshikawa R; Iwasaki K; Igarashi A
    J Med Econ; 2018 May; 21(5):443-449. PubMed ID: 29316823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers.
    Edge SB; Niland JC; Bookman MA; Theriault RL; Ottesen R; Lepisto E; Weeks JC
    J Natl Cancer Inst; 2003 Oct; 95(20):1514-21. PubMed ID: 14559873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.